David Richards

BACKGROUND:Domperidone, a D2 receptor antagonist, has been in clinical use in Europe and Asia since 1974. This drug is not FDA approved in USA. There are concerns about its cardiac toxicity, including QT prolongation, Torsade’s de pointes or sudden death…